Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study
Titel:
Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study
Auteur:
Bachelot, Thomas Romieu, Gilles Campone, Mario Diéras, Véronique Cropet, Claire Dalenc, Florence Jimenez, Marta Le Rhun, Emilie Pierga, Jean-Yves Gonçalves, Anthony Leheurteur, Marianne Domont, Julien Gutierrez, Maya Curé, Hervé Ferrero, Jean-Marc Labbe-Devilliers, Catherine